12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Lixte Biotechnology LIXT shares moved upwards by 67.2% to $3.77 during Wednesday's pre-market session. The market value of their outstanding shares is at $8.4 million.
  • Nutriband NTRB shares rose 24.34% to $3.78. The company's market cap stands at $31.9 million.
  • NovoCure NVCR stock rose 17.9% to $15.41. The company's market cap stands at $1.6 billion.
  • Strata Skin Sciences SSKN shares increased by 14.93% to $0.53. The market value of their outstanding shares is at $18.5 million. As per the news, the Q4 earnings report came out today.
  • Nuvation Bio NUVB shares moved upwards by 11.11% to $3.2. The market value of their outstanding shares is at $700.9 million.
  • MediciNova MNOV shares rose 10.29% to $1.5. The company's market cap stands at $73.5 million.

Losers

  • Akili AKLI stock decreased by 20.6% to $0.3 during Wednesday's pre-market session. The company's market cap stands at $23.7 million.
  • OpGen OPGN stock fell 15.67% to $0.63. The market value of their outstanding shares is at $6.3 million.
  • Mesoblast MESO shares declined by 14.76% to $3.35. The company's market cap stands at $339.9 million.
  • Altimmune ALT stock declined by 12.72% to $7.55. The market value of their outstanding shares is at $405.6 million. As per the press release, Q4 earnings came out today.
  • Concord Medical Services CCM stock decreased by 12.68% to $0.53. The company's market cap stands at $23.0 million.
  • PDS Biotechnology PDSB shares decreased by 12.28% to $3.93. The company's market cap stands at $122.2 million. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...